An AI that reads your face can now estimate how long you have to live

An AI that reads your face can now estimate how long you have to live

An AI that reads your face can now estimate how long you have to live

Story highlights

Researchers have built an AI trained on more than 40 million facial photographs that can estimate a person's biological age — and, in cancer patients, predict their chances of survival — from a single picture of their face. In testing, half the patients the model flagged as highest-risk died within 90 days. The scientists call it experimental, and it raises sharp questions about where such a tool should ever be allowed to point.

A photograph of a face has always carried clues about health — we all read tiredness, strain or illness in the people around us. Researchers have now trained an artificial intelligence to do it at a scale and precision no human can match, and the results are as unsettling as they are impressive.

What They Built

A team led by researchers at Mass General Brigham, publishing in The Lancet Digital Health, created a large AI model called FAHR-Face, trained on more than 40 million images of human faces.

From that foundation they built two tools. One, FAHR-FaceAge, estimates a person's 'biological age' — how old their body appears to be, as opposed to the years on their birth certificate. The other, FAHR-FaceSurvival, goes further: for cancer patients, it predicts survival directly from a facial photograph.

The Striking Numbers

The results are what make this land.

Trending Stories

Among cancer patients the survival model placed in its highest-risk 10 per cent, around half died within 90 days — compared with roughly 2 per cent of those in its lowest-risk 10 per cent. Separately, cancer patients whose AI-estimated biological age was at least five years older than their real age had about a 21 per cent higher risk of death over an average four-year follow-up. The survival model was trained on more than 34,000 patients and then tested on thousands more, including a validation group in the Netherlands.

Why This Is Powerful

A cheap, non-invasive signal — a single photo — that meaningfully sorts patients by risk could be genuinely useful in medicine.

Doctors already make 'eyeball' judgements about how frail or robust a patient looks, and those judgements influence treatment decisions. A tool that turns that instinct into a consistent, measurable estimate could help clinicians decide, for example, how aggressively an older or frailer cancer patient can be treated. In a world short of specialists, a reliable screening signal from something as ordinary as a photograph is not trivial.

Why It Is Also Alarming

And yet a machine that looks at your face and outputs your odds of dying is exactly the kind of technology that can go wrong in consequential hands.

The obvious fear is who else would want it. An insurer could use a face-based mortality estimate to set premiums or deny cover; an employer could use a biological-age score to quietly screen candidates; a government could use it in ways no one consented to. A prediction that is useful guidance in a doctor's hands becomes a tool of discrimination in others. And because the signal is a plain photograph, it could in principle be run on people without their knowledge.

The Honest Limits

Fairness demands the caveats, and the researchers themselves lead with them.

They call the tools experimental and not ready for clinical use. An independent expert cautioned the same. The models were validated on particular patient groups and need testing across far more diverse populations before anyone should trust them broadly, and an estimate of risk is a probability across a group, never a verdict on an individual — being flagged high-risk is not a death sentence, and being flagged low-risk is not a guarantee. The science is promising; the product is not here.

What To Watch

Whether the tool proves accurate and fair across different ethnicities, ages and conditions in prospective trials. Whether regulators draw lines around who may use face-based health prediction, and for what, before it leaks out of the clinic. And whether the clear medical upside can be captured without handing insurers, employers and states a new way to judge people by their faces.

About the Author

Tarun Mishra is a Sub-Editor at WION. He has worked with leading outlets doing investigative journalism and covering business, global affairs, technology, space exploration etc. Hi...Read More